Carroll PR - Search Results

1

Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS.

Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW. Kearns JT, et al. Among authors: carroll pr. J Urol. 2019 Jan;201(1):106-111. doi: 10.1016/j.juro.2018.07.065. J Urol. 2019. PMID: 30076904 Free PMC article.

2

Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging.

Carroll PR, Sugimura K, Cohen MB, Hricak H. Carroll PR, et al. J Urol. 1992 Feb;147(2):402-6. doi: 10.1016/s0022-5347(17)37249-x. J Urol. 1992. PMID: 1370698

3

Continence after radical cystoprostatectomy and total bladder replacement: a urodynamic analysis.

Gasparini ME, Hinman F Jr, Presti JC Jr, Schmidt RA, Carroll PR. Gasparini ME, et al. Among authors: carroll pr. J Urol. 1992 Dec;148(6):1861-4. doi: 10.1016/s0022-5347(17)37050-7. J Urol. 1992. PMID: 1433621

4

Acquired immunodeficiency syndrome-related Kaposi's sarcoma of the male genitalia: management with radiation therapy.

Vapnek JM, Quivey JM, Carroll PR. Vapnek JM, et al. Among authors: carroll pr. J Urol. 1991 Aug;146(2):333-6. doi: 10.1016/s0022-5347(17)37785-6. J Urol. 1991. PMID: 1856928

5

Testicular carcinoma in patients positive and at risk for human immunodeficiency virus.

Wilkinson M, Carroll PR. Wilkinson M, et al. Among authors: carroll pr. J Urol. 1990 Nov;144(5):1157-9. doi: 10.1016/s0022-5347(17)39680-5. J Urol. 1990. PMID: 2231890

6

Pathophysiology of urinary incontinence after radical prostatectomy.

Presti JC Jr, Schmidt RA, Narayan PA, Carroll PR, Tanagho EA. Presti JC Jr, et al. Among authors: carroll pr. J Urol. 1990 May;143(5):975-8. doi: 10.1016/s0022-5347(17)40155-8. J Urol. 1990. PMID: 2329614

7

Treatment options for hormone-insensitive or independent prostatic carcinoma.

Carroll PR, Narayan P. Carroll PR, et al. Semin Urol. 1988 Nov;6(4):322-35. Semin Urol. 1988. PMID: 3068770 Review. No abstract available.

8

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR. Roach M 3rd, et al. Among authors: carroll pr. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):33-7. doi: 10.1016/0360-3016(94)90138-4. Int J Radiat Oncol Biol Phys. 1994. PMID: 7505775 Review.

9

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.

Small EJ, Carroll PR. Small EJ, et al. Among authors: carroll pr. Urology. 1994 Mar;43(3):408-10. doi: 10.1016/0090-4295(94)90092-2. Urology. 1994. PMID: 7510915

10

Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.

Shinohara K, Wolf JS Jr, Narayan P, Carroll PR. Shinohara K, et al. Among authors: carroll pr. J Urol. 1994 Jul;152(1):120-3. doi: 10.1016/s0022-5347(17)32832-x. J Urol. 1994. PMID: 7515447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

817 results

Search Page